1. Home
  2. Live Updates
  3. Healthcare support services

Live Breaking News & Updates on Healthcare support services

Stay informed with the latest breaking news from Healthcare support services on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Healthcare support services and stay connected to the pulse of your community

S&P 500 Futures Fall in Premarket Trading; Okta, Duolingo Lead

With U.S. stock markets set to open in two hours, (OKTA) was up 25.1% in pre-market trading, and (DUOL) was up 19.2%. (NTRA), (PSTG), and (ELAN) were all...

Natera-inc , Elanco-animal-health-inc , Pure-storage-inc , Doubleverify-holdings-inc , Snowflake-inc , Duolingo-inc , Okta-inc , Pure-storage , Elanco-animal-health , Doubleverify-holdings , Article-normal

US Futures Flat, European Stocks Mostly Rise

U.S. futures for the S&P 500 were flat and futures for the Dow Jones Industrial Average were flat. Changes in futures do not necessarily predict movements...

Shanghai , China , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Germany , Japan , France , German , Zealand-pharma , Stoxx-europe ,

Opinion: Why the U.S. economy could repeat Japan's 'lost decade'

The real danger for the U.S. —as it was for Japan — is that industrial policies encourage investors to take poorly measured risks.

Japan , Elon-musk , Spacex , Microsoft , Meta-platforms , Article-opinion , Nikkei , Government , Keiretsu , Lostdecade , Stocks , Stockmarket

Ligand Pharmaceuticals Shares Rise 21% on 4Q Results Above Estimates

By Denny Jacob Ligand Pharmaceuticals shares were 21% higher at $89.98 following better-than-expected results in its fourth quarter. The stock is up about...

Denny-jacob , Ligand-pharmaceuticals , Article-normal , Pharmaceuticals , Scientific-research-services , Healthcare-life-sciences , Business-consumer-services , Medical-research-services , Drug-discovery-development , Healthcare-support-services , Diagnostic-medical-research-services , Financial-performance

Verve Therapeutics Shares Gain 16% On 4Q Revenue Beat

By Ben Glickman Shares of Verve Therapeutics rose Tuesday after fourth-quarter collaboration revenue came in ahead of expectations. The stock was up 16% to...

Boston , Massachusetts , United-states , Sekar-kathiresan , Ben-glickman , Eli-lilly , Vertex-pharmaceuticals , Verve-therapeutics , Executive-sekar-kathiresan , Article-normal , Biotechnology-services , Pharmaceuticals

FDA Officially Withdraws Approval of Oncopeptides Pepaxto

By Colin Kellaher The Food and Drug Administration has officially pulled its authorization of the anticancer drug Pepaxto from Swedish biotech Oncopeptides....

Sweden , Swedish , Colin-kellaher , Drug-administration , Article-normal , Pharmaceuticals , Cancer-drugs , Scientific-research-services , Healthcare-life-sciences , Business-consumer-services , Specialized-drugs-medications , Medical-research-services

Phillips and F.P. Journe to Sell Unique Piece to Benefit Breast Cancer Research

Journe spent eight years in research and development to come up with the slim, tonneau-shaped Élégante with a white luminescent dial

Geneva , Genè , Switzerland , Miami , Florida , United-states , Swiss , Paul-journe , Breast-cancer-research-foundation , Cotes-de-gen , Article-normal , Own

Sonic Healthcare 1H Net Profit A$202.3 Million, Down 47% on Year

By David Winning SYDNEY--Sonic Healthcare said its net profit fell by 47% on a steep drop in Covid-19 testing volumes, but it has benefited from recent...

Australia , Sydney , New-south-wales , Australian , Colin-goldschmidt , Sonic-healthcare , Utah-based-pathology-watch , Executive-colin-goldschmidt , David-winning , Article-normal , Healthcare-life-sciences

Monopar Therapeutics Shares Surge on Australia Antibody-Trial Clearance

By Sabela Ojea Shares of Monopar Therapeutics on Tuesday rose sharply after the company said it received clearance in Australia to begin a phase 1 dosimetry...

Australia , Sabela-ojea , Monopar-therapeutics , Article-normal , Biotechnology-services , Pharmaceuticals , Scientific-research-services , Healthcare-life-sciences , Business-consumer-services , Biopharmaceuticals , Medical-research-services

Labcorp Posts Higher 4Q Revenue

By Will Feuer Laboratory Corporation of America reported higher fourth-quarter revenue, lifted by strength in its core business that offset softening sales...

United-states , America , Laboratory-corporation-of-america , Article-normal , Healthcare-life-sciences , Medical-laboratory-services , Healthcare-support-services , Diagnostic-medical-research-services , Financial-performance , Earnings , Sales-figures